PRECISE: Pancreatic Cancer and Exercise

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

July 31, 2022

Study Completion Date

August 1, 2022

Conditions
Pancreas Adenocarcinoma
Interventions
OTHER

Exercise

Exercise programs will be individually tailored to the capabilities of each participant and gradually progressed accordingly. Each patient will be asked to complete one home-based aerobic exercise sessions each week. At baseline, 16 weeks and 3 month followup patients will complete a physical fitness assessment (30 second sit to stand and six minute walking tests) and a range of quality of life questionnaires. Upon completion of the 16 week exercise intervention, patients will be invited to partake in semi-structured interviews to determine the effectiveness of the program and their experience throughout.

Trial Locations (1)

BT5 5JU

Belfast City Hospital, Belfast

All Listed Sponsors
collaborator

Pancreatic Cancer UK

OTHER

collaborator

Belfast Health and Social Care Trust

OTHER

lead

Queen's University, Belfast

OTHER

NCT04305067 - PRECISE: Pancreatic Cancer and Exercise | Biotech Hunter | Biotech Hunter